Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


30.10.2017

2 Anticancer Res
1 Br J Dermatol
1 Gene
1 J Am Acad Dermatol
1 J Immunol
1 J Invest Dermatol
4 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. MA YS, Hsiao YT, Lin JJ, Liao CL, et al
    Phenethyl Isothiocyanate (PEITC) and Benzyl Isothiocyanate (BITC) Inhibit Human Melanoma A375.S2 Cell Migration and Invasion by Affecting MAPK Signaling Pathway In Vitro.
    Anticancer Res. 2017;37:6223-6234.
    PubMed     Text format     Abstract available

  2. NAJEM A, Krayem M, Perdrix A, Kerger J, et al
    New Drug Combination Strategies in Melanoma: Current Status and Future Directions.
    Anticancer Res. 2017;37:5941-5953.
    PubMed     Text format     Abstract available


    Br J Dermatol

  3. MONTAUDIE H, Pradelli J, Passeron T, Lacour JP, et al
    Pulmonary sarcoid-like granulomatosis induced by nivolumab.
    Br J Dermatol. 2017;176:1060-1063.
    PubMed     Text format     Abstract available


    Gene

  4. ZHANG K, Guo L
    MiR-767 promoted cell proliferation in human melanoma by suppressing CYLD expression.
    Gene. 2017 Oct 17. pii: S0378-1119(17)30901-0. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  5. CONIC RZ, Cabrera CI, Khorana AA, Gastman BR, et al
    Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.
    J Am Acad Dermatol. 2017 Sep 27. pii: S0190-9622(17)32300.
    PubMed     Text format     Abstract available


    J Immunol

  6. DING Q, Mohib K, Kuchroo VK, Rothstein DM, et al
    TIM-4 Identifies IFN-gamma-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection.
    J Immunol. 2017;199:2585-2595.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  7. RUBEL F, Kern JS, Technau-Hafsi K, Uhrich S, et al
    Indoleamine 2,3-dioxygenase expression in primary cutaneous melanoma correlates with Breslow thickness and is of significant prognostic value for progression-free survival.
    J Invest Dermatol. 2017 Oct 17. pii: S0022-202X(17)33059.
    PubMed     Text format     Abstract available


    Oncogene

  8. ARAIZA-OLIVERA D, Feng Y, Semenova G, Prudnikova TY, et al
    Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  9. DIETRICH P, Kuphal S, Spruss T, Hellerbrand C, et al
    Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  10. KIM KJ, Kwon SH, Yun JH, Jeong HS, et al
    STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression.
    Oncogene. 2017;36:5445-5459.
    PubMed     Text format     Abstract available

  11. KUO TF, Chen TY, Jiang ST, Chen KW, et al
    Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway.
    Oncogene. 2017;36:5484-5496.
    PubMed     Text format     Abstract available


    PLoS One

  12. VANDEREYKEN M, Jacques S, Van Overmeire E, Amand M, et al
    Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    PLoS One. 2017;12:e0185786.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: